Fogarty International Center; Notice of Meeting, 2948-2949 [2023-00765]
Download as PDF
<![CDATA[
2948
Federal Register / Vol. 88, No. 11 / Wednesday, January 18, 2023 / Notices
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Arthritis and
Musculoskeletal and Skin Diseases Initial
Review Group; Arthritis and Musculoskeletal
and Skin Diseases Special Grants Study
Section.
Date: March 2–3, 2023.
Time: 9:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Arthritis and
Musculoskeletal and Skin Diseases, 6701
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Helen Lin, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute of Arthritis,
Musculoskeletal and Skin Diseases, NIH,
6701 Democracy Boulevard, Suite 800,
Bethesda, MD 20892, 301–594–4952, linh1@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: January 11, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–00741 Filed 1–17–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Minority Health
and Health Disparities; Notice of
Closed Meetings
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Minority Health and Health Disparities
Special Emphasis Panel; NIMHD Mentored
Career and Research Development Awards
(Ks).
Date: February 23–24, 2023.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
17:41 Jan 17, 2023
Jkt 259001
Place: National Institutes of Health,
NIMHD, DEM II, Suite 800, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Deborah Ismond, Ph.D.,
Scientific Review Officer, Office of
Extramural Research Administration,
National Institute on Minority Health and
Health Disparities, National Institutes of
Health, 6707 Democracy Blvd., Suite 800,
Bethesda, MD 20892, (301) 594–2704,
ismonddr@mail.nih.gov.
Name of Committee: National Institute on
Minority Health and Health Disparities,
Special Emphasis Panel; Misinformation
among Populations that Experience Health
Disparities (R01—Clinical Trials Optional).
Date: March 16, 2023.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
NIMHD, DEM II, Suite 800, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Karen Nieves-Lugo,
M.P.H., Ph.D., Scientific Review Officer,
Office of Extramural Research Activities,
National Institute on Minority Health and
Health Disparities, National Institutes of
Health, 6707 Democracy Blvd., Suite 800,
Bethesda, MD 20892, (301) 480–4727,
karen.nieveslugo@nih.gov.
Name of Committee: National Institute on
Minority Health and Health Disparities
Special Emphasis Panel; NIH Support for
Conferences and Scientific Meetings (R13).
Date: March 17, 2023.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
NIMHD, DEM II, Suite 800, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Ivan K. Navarro, Ph.D.,
Scientific Review Officer, Office of
Extramural Research Administration,
National Institute on Minority Health and
Health Disparities, National Institutes of
Health, 6707 Democracy Blvd., Suite 800,
Bethesda, MD 20892, 301–827–2061,
ivan.navarro@nih.gov.
Dated: January 12, 2023.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–00874 Filed 1–17–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Communication
Disorders Review Committee.
Date: February 9–10, 2023.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Garden Inn Orlando at
Seaworld Orlando, FL.
Contact Person: Kausik Ray, Ph.D.,
Scientific Review Officer, National Institute
on Deafness and Other, Communication
Disorders, National Institute of Health, 6001
Executive Blvd. Rockville, MD 20850, 301–
402–3587, rayk@nidcd.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.173, Biological Research
Related to Deafness and Communicative
Disorders, National Institutes of Health, HHS)
Dated: January 11, 2023.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–00752 Filed 1–17–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Fogarty International Center; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Fogarty International
Center Advisory Board.
The meeting will be open to the
public as indicated below. The open
session can be accessed from the
Fogarty International Center website
https://www.fic.nih.gov/About/
Advisory/Pages/default.aspx. Members
of the public are encouraged to attend
virtually as space is limited. Individuals
who plan to attend as well as those who
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
E:\FR\FM\18JAN1.SGM
18JAN1
Federal Register / Vol. 88, No. 11 / Wednesday, January 18, 2023 / Notices
lotter on DSK11XQN23PROD with NOTICES1
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Fogarty
International Center Advisory Board.
Date: February 6–7, 2023.
Closed: February 6, 2023, 1:00 p.m. to
4:00 p.m.
Agenda: To review and evaluate the
second level of grant applications.
Place: Fogarty International Center,
National Institutes of Health, Lawton
Chiles International House (Stone
House), 16 Center Drive, Conference
Room, Bethesda, MD 20892.
Open: February 7, 2023, 9:00 a.m. to
3:00 p.m.
Agenda: Update and discussion of
current and planned Fogarty
International Center activities.
Place: Fogarty International Center,
National Institutes of Health, Lawton
Chiles International House (Stone
House), 16 Center Drive, Conference
Room, Bethesda, MD 20892 (Virtual
Meeting).
Meeting Access: https://
www.fic.nih.gov/About/Advisory/Pages/
default.aspx.
Contact Person: Kristen Weymouth,
Executive Secretary, Fogarty
International Center, National Institutes
of Health, 31 Center Drive, Room
B2C02, Bethesda, MD 20892, 301–496–
1415, kristen.weymouth@nih.gov.
Any interested person may file
written comments with the committee
by forwarding the statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
procedures at https://www.nih.gov/
about-nih/visitor-information/campusaccess-security for entrance into oncampus and off-campus facilities. All
visitor vehicles, including taxicabs,
hotel, and airport shuttles will be
inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal
facility will be asked to show one form
of identification (for example, a
government-issued photo ID, driver’s
license, or passport) and to state the
purpose of their visit.
Additional Health and Safety
Guidance: Before attending a meeting at
an NIH facility, it is important that
visitors review the NIH COVID–19
VerDate Sep<11>2014
17:41 Jan 17, 2023
Jkt 259001
Safety Plan at https://ors.od.nih.gov/sr/
dohs/safety/NIH-covid-19-safety-plan/
Pages/default.aspx for information
about requirements and procedures for
entering NIH facilities, especially when
COVID–19 community levels are
medium or high. In addition, the Safer
Federal Workforce website has FAQs for
visitors at https://www.saferfederal
workforce.gov/faq/visitors/. Please note
that if an individual has a COVID–19
diagnosis within 10 days of the meeting,
that person must attend virtually. (For
more information please read NIH’s
Requirements for Persons after Exposure
at https://ors.od.nih.gov/sr/dohs/safety/
NIH-covid-19-safety-plan/COVIDassessment-testing/Pages/persons-afterexposure.aspx and What Happens When
Someone Tests Positive at https://
ors.od.nih.gov/sr/dohs/safety/NIHcovid-19-safety-plan/COVIDassessment-testing/Pages/test-positive.
aspx.) Anyone from the public can
attend the open portion of the meeting
virtually via the NIH Videocasting
website (https://videocast.nih.gov).
Please continue checking these
websites, in addition to the committee
website listed below, for the most up to
date guidance as the meeting date
approaches.
Information is also available on the
Institute’s/Center’s home page: https://
www.fic.nih.gov/About/Advisory/Pages/
default.aspx, where an agenda and any
additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.106, Minority International
Research Training Grant in the Biomedical
and Behavioral Sciences; 93.154, Special
International Postdoctoral Research Program
in Acquired Immunodeficiency Syndrome;
93.168, International Cooperative
Biodiversity Groups Program; 93.934, Fogarty
International Research Collaboration Award;
93.989, Senior International Fellowship
Awards Program, National Institutes of
Health, HHS)
Dated: January 11, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–00765 Filed 1–17–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
2949
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel; NIAMS
Mechanistic Ancillary Studies Review
Meeting.
Date: February 27, 2023.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Arthritis and
Musculoskeletal and Skin Diseases, 6701
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Kan Ma, Ph.D., Scientific
Review Officer, Scientific Review Branch,
National Institute of Arthritis,
Musculoskeletal and Skin Diseases, NIH,
6701 Democracy Boulevard, Suite 814,
Bethesda, MD 20892, 301–451–4838, mak2@
mail.nih.gov.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel; NIAMS
AMS Member Conflict Review Meeting.
Date: February 27, 2023.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Arthritis and
Musculoskeletal and Skin Diseases, 6701
Democracy Boulevard Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Bernard Joseph
Dardzinski, Ph.D., Scientific Review Officer,
Scientific Review Branch, National Institute
of Arthritis, Musculoskeletal and Skin
Diseases, NIH, 6701 Democracy Boulevard.,
Room 824, Plaza One, Bethesda, MD 20817,
301–435–1146, bernard.dardzinski@nih.gov.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel; NIAMS
AMSC Member Conflict Review Meeting.
Date: March 8, 2023.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Arthritis and
Musculoskeletal and Skin Diseases, 6701
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Helen Lin, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute of Arthritis,
Musculoskeletal and Skin Diseases, NIH,
6701 Democracy Boulevard, Suite 800,
Bethesda, MD 20892, 301–594–4952, linh1@
mail.nih.gov.
E:\FR\FM\18JAN1.SGM
18JAN1
]]>Agencies
[Federal Register Volume 88, Number 11 (Wednesday, January 18, 2023)]
[Notices]
[Pages 2948-2949]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-00765]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Fogarty International Center; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Fogarty
International Center Advisory Board.
The meeting will be open to the public as indicated below. The open
session can be accessed from the Fogarty International Center website
https://www.fic.nih.gov/About/Advisory/Pages/default.aspx. Members of
the public are encouraged to attend virtually as space is limited.
Individuals who plan to attend as well as those who need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C.,
[[Page 2949]]
as amended. The grant applications and the discussions could disclose
confidential trade secrets or commercial property such as patentable
material, and personal information concerning individuals associated
with the grant applications, the disclosure of which would constitute a
clearly unwarranted invasion of personal privacy.
Name of Committee: Fogarty International Center Advisory Board.
Date: February 6-7, 2023.
Closed: February 6, 2023, 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate the second level of grant
applications.
Place: Fogarty International Center, National Institutes of Health,
Lawton Chiles International House (Stone House), 16 Center Drive,
Conference Room, Bethesda, MD 20892.
Open: February 7, 2023, 9:00 a.m. to 3:00 p.m.
Agenda: Update and discussion of current and planned Fogarty
International Center activities.
Place: Fogarty International Center, National Institutes of Health,
Lawton Chiles International House (Stone House), 16 Center Drive,
Conference Room, Bethesda, MD 20892 (Virtual Meeting).
Meeting Access: https://www.fic.nih.gov/About/Advisory/Pages/default.aspx.
Contact Person: Kristen Weymouth, Executive Secretary, Fogarty
International Center, National Institutes of Health, 31 Center Drive,
Room B2C02, Bethesda, MD 20892, 301-496-1415, [email protected].
Any interested person may file written comments with the committee
by forwarding the statement to the Contact Person listed on this
notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person.
In the interest of security, NIH has procedures at https://www.nih.gov/about-nih/visitor-information/campus-access-security for
entrance into on-campus and off-campus facilities. All visitor
vehicles, including taxicabs, hotel, and airport shuttles will be
inspected before being allowed on campus. Visitors attending a meeting
on campus or at an off-campus federal facility will be asked to show
one form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their visit.
Additional Health and Safety Guidance: Before attending a meeting
at an NIH facility, it is important that visitors review the NIH COVID-
19 Safety Plan at https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/Pages/default.aspx for information about requirements and
procedures for entering NIH facilities, especially when COVID-19
community levels are medium or high. In addition, the Safer Federal
Workforce website has FAQs for visitors at https://www.saferfederalworkforce.gov/faq/visitors/. Please note that if an
individual has a COVID-19 diagnosis within 10 days of the meeting, that
person must attend virtually. (For more information please read NIH's
Requirements for Persons after Exposure at https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/persons-after-exposure.aspx and What Happens When Someone Tests
Positive at https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/test-positive.aspx.) Anyone from
the public can attend the open portion of the meeting virtually via the
NIH Videocasting website (https://videocast.nih.gov). Please continue
checking these websites, in addition to the committee website listed
below, for the most up to date guidance as the meeting date approaches.
Information is also available on the Institute's/Center's home
page: https://www.fic.nih.gov/About/Advisory/Pages/default.aspx, where
an agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.106,
Minority International Research Training Grant in the Biomedical and
Behavioral Sciences; 93.154, Special International Postdoctoral
Research Program in Acquired Immunodeficiency Syndrome; 93.168,
International Cooperative Biodiversity Groups Program; 93.934,
Fogarty International Research Collaboration Award; 93.989, Senior
International Fellowship Awards Program, National Institutes of
Health, HHS)
Dated: January 11, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-00765 Filed 1-17-23; 8:45 am]
BILLING CODE 4140-01-P
